Michael Coleman, Ph.D.
Senior Vice President, Strategy
Dr. Coleman has more than 24 years of product development experience in the biotechnology, medical device, and pharmaceutical industries. During his career Dr. Coleman has:
- Successfully lead product focused research teams, headed the R&D function at a biotechnology subsidiary of a major pharmaceutical company, and served as CEO of a medical device company from start-up through regulatory approval and commercialization
- Managed successful IND filing and early clinical development of gene-based immunotherapies, overseen a large international phase 2 program of an angiogenesis therapy for critical limb ischemia that progressed to phase 3 trials at a large pharma commercial partner, and obtained approval under CE Mark and US FDA 510K for medical devices involved in tissue handling and cell preparation
- Raised over $15 million in equity funding and has extensive expertise in aligning development budgets with funding to meet regulatory requirements to efficiently and expeditiously move product development forward